Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 06/6/23 → 02/28/26 |
Funding
- Capricor Incorporated: $21,303.00
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Human Allogeneic Cardiosphere-Derived Cells for the Treatment of Duchenne Muscular Dystrophy
- Treidler, Simona (PI)
- Dawson, Dawn Michelle (CoPI)
- Morelli, Peter (CoPI)
Project: Research